nanotechnology « Science and Enterprise

Dual-Action Vaccine Shown to Attack, Shrink Solid Tumors

By Alan, on October 27th, 2022%

Research with lab animals shows an experimental cancer vaccine generates immune-system cells that infiltrate solid tumors and reduce the tumor’s protective environment. . . . → Read More: Dual-Action Vaccine Shown to Attack, Shrink Solid Tumors

RNA Cancer Immunotherapy Shown Feasible in Preclinical Test

By Alan, on October 7th, 2022%

Tests with lab animals show synthetic viral RNA particles, encased in natural oils, can safely invoke an immune response to attack solid tumors. . . . → Read More: RNA Cancer Immunotherapy Shown Feasible in Preclinical Test

Cell, mRNA Therapy Biotech Raises $165M in Early Funds

By Alan, on September 14th, 2022%

A new company, founded by university medical researchers, is developing cell therapies engineered with messenger RNA or mRNA to work inside the body. . . . → Read More: Cell, mRNA Therapy Biotech Raises $165M in Early Funds

CEPI Funds New Broad Coronavirus Vaccine

By Alan, on July 5th, 2022%

An international health group is funding a new vaccine to cover a broad range of coronaviruses using exosomes, tiny natural bubbles for delivery to cells. . . . → Read More: CEPI Funds New Broad Coronavirus Vaccine

Semiconductor Tech Drug Discovery Company Underway

By Alan, on April 28th, 2022%

A drug discovery company with an electronic screening process based on semiconductor technology is starting up and raising $9.25 million in seed funds. . . . → Read More: Semiconductor Tech Drug Discovery Company Underway

NIH Funding Nanoparticle Gene Therapy for Opioid Disorder

By Alan, on April 1st, 2022%

National Institutes of Health is funding research on an experimental gene therapy delivered with nanoparticles to treat opioid use disorder. . . . → Read More: NIH Funding Nanoparticle Gene Therapy for Opioid Disorder

New Industry, Academic Studies Arrive at Space Station

By Alan, on February 21st, 2022%

Several experiments from companies and academic labs arrived today at the International Space Station to test effects of microgravity and other conditions. . . . → Read More: New Industry, Academic Studies Arrive at Space Station

Exosomes Shown to Block Broad Covid-19 Variant Range

By Alan, on January 20th, 2022%

Tiny natural bubbles with infection-receptor proteins found in blood are shown in lab mice to divert and prevent SARS-CoV-2 viruses from infecting real cells. . . . → Read More: Exosomes Shown to Block Broad Covid-19 Variant Range

Biotech Partners on Gene Editing Tech in $1.35B Deal

By Alan, on January 10th, 2022%

A biotechnology company is making its precise gene editing technology available to drug maker Pfizer for rare diseases, in a deal valued at $1.35 billion. . . . → Read More: Biotech Partners on Gene Editing Tech in $1.35B Deal

Trial Set for Covid-19 Nasal Spray Vaccine

By Alan, on January 5th, 2022%

A clinical trial testing a vaccine to protect against Covid-19 disease, given as a nasal spray, is scheduled to begin later this year in the Netherlands. . . . → Read More: Trial Set for Covid-19 Nasal Spray Vaccine

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise